P

Inventor

MCWHIRTER JOHN

US82 patents
⚠️ This page may combine multiple inventors who share the name “MCWHIRTER JOHN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

REGENERON PHARMA

33 patents
US10412940B2Sep 17, 2019

Mice expressing a limited immunoglobulin light chain repertoire

REGENERON PHARMA38 citations98
US9113616B2Aug 25, 2015

Genetically modified mice having humanized TCR variable genes

REGENERON PHARMA67 citations97
US9796788B2Oct 24, 2017

Mice expressing a limited immunoglobulin light chain repertoire

REGENERON PHARMA26 citations94
US9334334B2May 10, 2016

Histidine engineered light chain antibodies and genetically modified non-human animals for generating the same

REGENERON PHARMA31 citations94
US9301510B2Apr 5, 2016

Mice that produce antigen-binding proteins with pH-dependent binding characteristics

REGENERON PHARMA28 citations94
US9204624B2Dec 8, 2015

Non-human animals with modifed immunoglobulin heavy chain sequences

REGENERON PHARMA30 citations94
US9332742B2May 10, 2016

Histidine engineered light chain antibodies and genetically modified non-human animals for generating the same

REGENERON PHARMA19 citations93
US9795121B2Oct 24, 2017

Humanized C3 animals

REGENERON PHARMA18 citations92
US9738897B2Aug 22, 2017

Nuclease-mediated DNA assembly

REGENERON PHARMA13 citations91
US11559050B2Jan 24, 2023

Humanized non-human animals with restricted immunoglobulin heavy chain loci

REGENERON PHARMA4 citations86
US9969814B2May 15, 2018

Methods for making fully human bispecific antibodies using a common light chain

REGENERON PHARMA18 citations86
US10246509B2Apr 2, 2019

Restricted immunoglobulin heavy chain mice

REGENERON PHARMA6 citations84
US10238093B2Mar 26, 2019

Humanized non-human animals with restricted immunoglobulin heavy chain loci

REGENERON PHARMA12 citations84
US10167344B2Jan 1, 2019

Mice expressing a limited immunoglobulin light chain repertoire

REGENERON PHARMA7 citations84
US9930871B2Apr 3, 2018

Non-human animals with modified immunoglobulin heavy chain sequences

REGENERON PHARMA7 citations84
US9801362B2Oct 31, 2017

Non-human animals expressing pH-sensitive immunoglobulin sequences

REGENERON PHARMA9 citations84
US9730435B2Aug 15, 2017

Non-human animals having a humanized a proliferation-inducing ligand gene

REGENERON PHARMA5 citations84
US9648856B2May 16, 2017

Non-human animals expressing pH-sensitive immunoglobulin sequences

REGENERON PHARMA9 citations84
US9629347B2Apr 25, 2017

Non-human animals having a humanized B-cell activating factor gene

REGENERON PHARMA6 citations84
US9615550B2Apr 11, 2017

Genetically modified major histocompatibility complex mice

REGENERON PHARMA12 citations84
US9591835B2Mar 14, 2017

Genetically modified major histocompatibility complex animals

REGENERON PHARMA11 citations84
US9963501B2May 8, 2018

B cell lineage based immunogen design with humanized animals

REGENERON PHARMA6 citations82
US9580715B2Feb 28, 2017

Nuclease-mediated DNA assembly

REGENERON PHARMA7 citations82
US12389888B2Aug 19, 2025

Mice expressing a limited immunoglobulin light chain repertoire

REGENERON PHARMA1 citations75
US11666040B2Jun 6, 2023

Humanized non-human animals with restricted immunoglobulin heavy chain loci

REGENERON PHARMA3 citations73
US11528895B2Dec 20, 2022

Genetically modified T cell receptor mice

REGENERON PHARMA2 citations73
US11261248B2Mar 1, 2022

Restricted immunoglobulin heavy chain mice

REGENERON PHARMA2 citations73
US11026407B2Jun 8, 2021

Mice expressing a limited immunoglobulin light chain repertoire

REGENERON PHARMA2 citations73
US11000020B2May 11, 2021

Non-human animals having a humanized B-cell activating factor gene

REGENERON PHARMA1 citations73
US10869466B2Dec 22, 2020

Genetically modified major histocompatibility complex mice

REGENERON PHARMA2 citations73
US10219494B2Mar 5, 2019

Non-human animals having a humanized B-cell activating factor gene

REGENERON PHARMA2 citations73
US11051498B2Jul 6, 2021

Mouse having an engineered immunoglobulin lambda light chain

REGENERON PHARMA2 citations72
US10820582B2Nov 3, 2020

Non-human animals having an engineered immunoglobulin Λ light chain locus

REGENERON PHARMA3 citations71

ALEXION PHARMA INC

6 patents

BOWDISH KATHERINE S

5 patents

MCWHIRTER JOHN

2 patents

LENSAR INC

2 patents

REGENERAN PHARMACEUTICALS INC

1 patent

CURATU GEORGE C

1 patent

Showing the top 50 of 82 patents by PatentIndex Score.